Glucocorticoids in rheumatoid arthritis

Area of Science:

• Rheumatology
• Pharmacology
• Immunology

Background:

• Corticosteroids have a long history in rheumatoid arthritis (RA) management since the 1950s.
• Recent evidence highlights their rapid symptomatic relief, disease-modifying properties, and sub-clinical actions.
• A renewed interest in corticosteroids for RA treatment is driven by their acceptable safety profile, particularly at low doses.

Purpose of the Study:

• To re-evaluate the therapeutic potential of corticosteroids in rheumatoid arthritis (RA) treatment.
• To review optimized corticosteroid-based strategies for RA management, balancing clinical benefits and adverse effects.
• To clarify the optimal dose, timing, and administration routes for corticosteroids in RA.

Main Methods:

• Review of historical and recent clinical data on corticosteroid use in RA.
• Analysis of therapeutic approaches, including high-dose and low-dose regimens.
• Consideration of different administration routes and step-down schedules.

Main Results:

• High-dose corticosteroid schedules with step-down schemes show efficacy but are not always practical for real-world RA patient management.
• Low-dose corticosteroid administration demonstrates encouraging clinical and sub-clinical effects in RA.
• A shift towards low-dose corticosteroid use in daily RA practice is observed.

Conclusions:

• Corticosteroids remain a valuable therapeutic option for rheumatoid arthritis (RA).
• Low-dose corticosteroid therapy presents a promising approach for RA management, offering a favorable risk-benefit profile.
• Further clarification on optimal dosing, timing, and administration is essential for maximizing corticosteroid benefits in RA.